Anginex lipoplexes for delivery of anti-angiogenic siRNA

International Journal of Pharmaceutics

Volumn 472, Issue 1-2, 2014, Pages 175-184

  Yousefi, Afrouz ^a   Bourajjaj, Meriem ^a   Babae, Negar ^a   Noort, Paula I Van ^b   Schaapveld, Roel Q J ^b   Beijnum, Judy R Van ^c   Griffioen, Arjan W ^c   Storm, Gert ^a   Schiffelers, Raymond M ^d   Mastrobattista, Enrico ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b InteRNA Technologies BV   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Anginex; Angiogenesis; Lipoplex; Liposome; Nucleic acid delivery; siRNA

Indexed keywords

ANGINEX; ANGIPLEX; GALECTIN 1; LIPOPLEX; SMALL INTERFERING RNA; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; ANGINEX PEPTIDE; ANGIOGENESIS INHIBITOR; LIPID; PEPTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2, HUMAN;

AGAR GEL ELECTROPHORESIS; ANGIOGENESIS; ANTIANGIOGENIC THERAPY; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; GENE CONTROL; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGHT SCATTERING; MICROENCAPSULATION; PRIORITY JOURNAL; REFRACTION INDEX; RNA INTERFERENCE; TRANSMISSION ELECTRON MICROSCOPY; UMBILICAL VEIN ENDOTHELIAL CELL; ZETA POTENTIAL; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENETICS; METABOLISM;

ANGIOGENESIS INHIBITORS; CELL SURVIVAL; CELLS, CULTURED; GENE SILENCING; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPIDS; PEPTIDES; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84903178051     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.06.028     Document Type: Article

References (60)

1. L. Astorgues-Xerri, M.E. Riveiro, A. Tijeras-Raballand, M. Serova, C. Neuzillet, S. Albert, E. Raymond, and S. Faivre Unraveling galectin-1 as a novel therapeutic target for cancer Cancer Treat. Rev. 40 2014 307 319
2. G. Bergers, and L.E. Benjamin Tumorigenesis and the angiogenic switch Nat. Rev. Cancer 3 2003 401 410 (Pubitemid 37328844)
3. R.J. Brandwijk, W.J. Mulder, K. Nicolay, K.H. Mayo, V.L. Thijssen, and A.W. Griffioen Anginex-conjugated liposomes for targeting of angiogenic endothelial cells Bioconjug. Chem. 18 2007 785 790 (Pubitemid 47010798)
4. S. Chono, S.D. Li, C.C. Conwell, and L. Huang An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor J. Control. Release 131 2008 64 69
5. T.C. Chu, J.W. Marks 3rd., L.A. Lavery, S. Faulkner, M.G. Rosenblum, A.D. Ellington, and M. Levy Aptamer:toxin conjugates that specifically target prostate tumor cells Cancer Res. 66 2006 5989 5992
6. N. Clausse, F. van den Brule, D. Waltregny, F. Garnier, and V. Castronovo Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion Angiogenesis 3 1999 317 325 (Pubitemid 129643974)
7. N. D'Haene, S. Sauvage, C. Maris, I. Adanja, M. Le Mercier, C. Decaestecker, L. Baum, and I. Salmon VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis PLoS One 8 2013 e67029
8. S.W. Dow, L.G. Fradkin, D.H. Liggitt, A.P. Willson, T.D. Heath, and T.A. Potter Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously J. Immunol. 163 1999 1552 1561 (Pubitemid 29352779)
9. D.C. Drummond, M. Zignani, and J. Leroux Current status of pH-sensitive liposomes in drug delivery Prog. Lipid Res. 39 2000 409 460
10. H.F. Dvorak, L.F. Brown, M. Detmar, and A.M. Dvorak Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis Am. J. Pathol. 146 1995 1029 1039
11. A. Eichmann, C. Corbel, V. Nataf, P. Vaigot, C. Breant, and N.M. Le Douarin Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2 Proc. Natl. Acad. Sci. U. S. A. 94 1997 5141 5146 (Pubitemid 27214750)
12. M. Elsabahy, A. Nazarali, and M. Foldvari Non-viral nucleic acid delivery: key challenges and future directions Curr. Drug Deliv. 8 2011 235 244
13. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat. Med. 1 1995 27 31
14. J.A. Forsythe, B.H. Jiang, N.V. Iyer, F. Agani, S.W. Leung, R.D. Koos, and G.L. Semenza Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 Mol. Cell Biol. 16 1996 4604 4613 (Pubitemid 26272112)
15. R.N. Gacche, and R.J. Meshram Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth Prog. Biophys. Mol. Biol. 113 2013 333 354
16. A.W. Griffioen, and G. Molema Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation Pharmacol. Rev. 52 2000 237 268 (Pubitemid 30368433)
17. A.W. Griffioen, D.W. van der Schaft, A.F. Barendsz-Janson, A. Cox, H.A. Struijker Boudier, H.F. Hillen, and K.H. Mayo Anginex, a designed peptide that inhibits angiogenesis Biochem. J. 354 2001 233 242 (Pubitemid 32209858)
18. W. Guo, and R.J. Lee Efficient gene delivery using anionic liposome-complexed polyplexes (LPDII) Biosci. Rep. 20 2000 419 432 (Pubitemid 32280918)
19. X. Guo, J.A. MacKay, and F.C. Szoka Jr. Mechanism of pH-triggered collapse of phosphatidylethanolamine liposomes stabilized by an ortho ester polyethyleneglycol lipid Biophys. J. 84 2003 1784 1795 (Pubitemid 36322940)
20. J. Guo, K.A. Fisher, R. Darcy, J.F. Cryan, and C. O'Driscoll Therapeutic targeting in the silent era: advances in non-viral siRNA delivery Mol. Biosyst. 6 2010 1143 1161
21. S.H. Hsieh, N.W. Ying, M.H. Wu, W.F. Chiang, C.L. Hsu, T.Y. Wong, Y.T. Jin, T.M. Hong, and Y.L. Chen Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells Oncogene 27 2008 3746 3753 (Pubitemid 351912963)
22. H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth, W. Heim, J. Berlin, A. Baron, S. Griffing, E. Holmgren, N. Ferrara, G. Fyfe, B. Rogers, R. Ross, and F. Kabbinavar Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N. Engl. J. Med. 350 2004 2335 2342 (Pubitemid 38702844)
23. G. Kibria, H. Hatakeyama, N. Ohga, K. Hida, and H. Harashima Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery J. Control. Release 153 2011 141 148
24. E. Kluza, I. Jacobs, S.J. Hectors, K.H. Mayo, A.W. Griffioen, G.J. Strijkers, and K. Nicolay Dual-targeting of alphavbeta3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo J. Control. Release 158 2012 207 214
25. K.B. Knudsen, H. Northeved, P.K. Ek, A. Permin, T.L. Andresen, S. Larsen, K.M. Wegener, H.R. Lam, and J. Lykkesfeldt Differential toxicological response to positively and negatively charged nanoparticles in the rat brain Nanotoxicology 8 2014 764 774
26. M. Koldehoff, N.K. Steckel, D.W. Beelen, and A.H. Elmaagacli Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia Clin. Exp. Med. 7 2007 47 55 (Pubitemid 47036743)
27. I. Koltover, T. Salditt, J.O. Radler, and C.R. Safinya An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery Science 281 1998 78 81 (Pubitemid 28354046)
28. S.D. Li, and L. Huang Surface-modified LPD nanoparticles for tumor targeting Ann. N. Y. Acad. Sci. 1082 2006 1 8 (Pubitemid 44955442)
29. S.D. Li, and L. Huang Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells Mol. Pharm. 3 2006 579 588 (Pubitemid 44639135)
30. S.D. Li, Y.C. Chen, M.J. Hackett, and L. Huang Tumor-targeted delivery of siRNA by self-assembled nanoparticles Mol. Ther. 16 2008 163 169
31. Y. Liu, D. Liggitt, W. Zhong, G. Tu, K. Gaensler, and R. Debs Cationic liposome-mediated intravenous gene delivery J. Biol. Chem. 270 1995 24864 24870
32. Y. Liu, L.C. Mounkes, H.D. Liggitt, C.S. Brown, I. Solodin, T.D. Heath, and R.J. Debs Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery Nat. Biotechnol. 15 1997 167 173 (Pubitemid 27081784)
33. R. Lotan, P.N. Belloni, R.J. Tressler, D. Lotan, X.C. Xu, and G.L. Nicolson Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion Glycoconj. J. 11 1994 462 468 (Pubitemid 24363374)
34. D. Mahalingam, L. Malik, M. Beeram, J. Rodon, K. Sankhala, A. Mita, D. Benjamin, N. Ketchum, J. Michalek, A. Tolcher, J. Wright, and J. Sarantopoulos Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma Cancer Chemother. Pharmacol. 2014
35. E. Mastrobattista, R.H. Kapel, M.H. Eggenhuisen, P.J. Roholl, D.J. Crommelin, W.E. Hennink, and G. Storm Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells Cancer Gene Ther. 8 2001 405 413 (Pubitemid 32757957)
36. Y. Nie, D. Schaffert, W. Rodl, M. Ogris, E. Wagner, and M. Gunther Dual-targeted polyplexes: one step towards a synthetic virus for cancer gene therapy J. Control. Release 152 2011 127 134
37. S. Nimesh, N. Gupta, and R. Chandra Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids J. Biomed. Nanotechnol. 7 2011 504 520
38. A.K. Olsson, A. Dimberg, J. Kreuger, and L. Claesson-Welsh VEGF receptor signalling - in control of vascular function Nat. Rev. Mol. Cell Biol. 7 2006 359 371
39. P. Opanasopit, M. Nishikawa, and M. Hashida Factors affecting drug and gene delivery: effects of interaction with blood components Crit. Rev. Ther. Drug Carrier Syst. 19 2002 191 233 (Pubitemid 36231520)
40. S.D. Patil, D.G. Rhodes, and D.J. Burgess Biophysical characterization of anionic lipoplexes Biochim. Biophys. Acta 1711 2005 1 11 (Pubitemid 40726394)
41. M. Prewett, J. Huber, Y. Li, A. Santiago, W. O'Connor, K. King, J. Overholser, A. Hooper, B. Pytowski, L. Witte, P. Bohlen, and D.J. Hicklin Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors Cancer Res. 59 1999 5209 5218 (Pubitemid 29503984)
42. N. Rubinstein, M. Alvarez, N.W. Zwirner, M.A. Toscano, J.M. Ilarregui, A. Bravo, J. Mordoh, L. Fainboim, O.L. Podhajcer, and G.A. Rabinovich Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; a potential mechanism of tumor-immune privilege Cancer Cell 5 2004 241 251 (Pubitemid 38402116)
43. S. Simoes, V. Slepushkin, N. Duzgunes, and M.C. Pedroso de Lima On the mechanisms of internalization and intracellular delivery mediated by pH-sensitive liposomes Biochim. Biophys. Acta 1515 2001 23 37 (Pubitemid 32938223)
44. K. Sliva, and B.S. Schnierle Selective gene silencing by viral delivery of short hairpin RNA Virol. J. 7 2010 248
45. D.A. Smith, P. Conkling, D.A. Richards, J.J. Nemunaitis, T.E. Boyd, A.C. Mita, G. de La Bourdonnaye, D. Wages, and A.S. Bexon Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO -2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy Cancer Immunol. Immunother. 2014
46. K. Takara, H. Hatakeyama, G. Kibria, N. Ohga, K. Hida, and H. Harashima Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy J. Control. Release 162 2012 225 232
47. V.L. Thijssen, R. Postel, R.J. Brandwijk, R.P. Dings, I. Nesmelova, S. Satijn, N. Verhofstad, Y. Nakabeppu, L.G. Baum, J. Bakkers, K.H. Mayo, F. Poirier, and A.W. Griffioen Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy Proc. Natl. Acad. Sci. U. S. A. 103 2006 15975 15980 (Pubitemid 44657577)
48. C. Tros de Ilarduya, M.A. Arangoa, and N. Duzgunes Transferrin-lipoplexes with protamine-condensed DNA for serum-resistant gene delivery Methods Enzymol. 373 2003 342 356 (Pubitemid 41103293)
49. R. van der Meel, S. Oliveira, I. Altintas, R. Haselberg, J. van der Veeken, R.C. Roovers, P.M. van Bergen en Henegouwen, G. Storm, W.E. Hennink, R.M. Schiffelers, and R.J. Kok Tumor-targeted nanobullets: anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment J. Control. Release 159 2012 281 289
50. D.W. van der Schaft, R.P. Dings, Q.G. de Lussanet, L.I. van Eijk, A.W. Nap, R.G. Beets-Tan, J.C. Bouma-Ter Steege, J. Wagstaff, K.H. Mayo, and A.W. Griffioen The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models FASEB J. 16 2002 1991 1993
51. F.M. van de Water, O.C. Boerman, A.C. Wouterse, J.G. Peters, F.G. Russel, and R. Masereeuw Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules Drug Metab. Dispos. 34 2006 1393 1397 (Pubitemid 44079881)
52. P. Venugopalan, S. Jain, S. Sankar, P. Singh, A. Rawat, and S.P. Vyas pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects Pharmazie 57 2002 659 671 (Pubitemid 35221635)
53. Y. Wang, L. Zhang, S. Guo, A. Hatefi, and L. Huang Incorporation of histone derived recombinant protein for enhanced disassembly of core-membrane structured liposomal nanoparticles for efficient siRNA delivery J. Control. Release 172 2013 179 189
54. K. Yasuda, Y. Ogawa, I. Yamane, M. Nishikawa, and Y. Takakura Macrophage activation by a DNA/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways J. Leukoc. Biol. 77 2005 71 79 (Pubitemid 40310695)
55. S.Y. Yoo, and S.M. Kwon Angiogenesis and its therapeutic opportunities Mediators Inflamm. 2013 2013 127170
56. Y. Yu, and J.D. Sato MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor J. Cell Physiol. 178 1999 235 246 (Pubitemid 29034867)
57. Y. Zhang, N.M. Schwerbrock, A.B. Rogers, W.Y. Kim, and L. Huang Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC Mol. Ther. 21 2013 1559 1569
58. J. Zhou, K. Tiemann, P. Chomchan, J. Alluin, P. Swiderski, J. Burnett, X. Zhang, S. Forman, R. Chen, and J. Rossi Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells Nucleic Acids Res. 41 2013 4266 4283
59. L. Zhu, and R.I. Mahato Lipid and polymeric carrier-mediated nucleic acid delivery Expert Opin. Drug Deliv. 7 2010 1209 1226
60. T.S. Zimmermann, A.C. Lee, A. Akinc, B. Bramlage, D. Bumcrot, M.N. Fedoruk, J. Harborth, J.A. Heyes, L.B. Jeffs, M. John, A.D. Judge, K. Lam, K. McClintock, L.V. Nechev, L.R. Palmer, T. Racie, I. Rohl, S. Seiffert, S. Shanmugam, V. Sood, J. Soutschek, I. Toudjarska, A.J. Wheat, E. Yaworski, W. Zedalis, V. Koteliansky, M. Manoharan, H.P. Vornlocher, and I. MacLachlan RNAi-mediated gene silencing in non-human primates Nature 441 2006 111 114